Literature DB >> 9025690

Immunogenicity of the nonrepetitive regions of the circumsporozoite protein of Plasmodium knowlesi.

S Sharma1, A Goswami, N J Singh, L Kabilan, S S Deodhar.   

Abstract

The circumsporozoite antigen (CS) of the simian malarial parasite Plasmodium knowlesi consists of tandemly repeated immunodominant peptide units that are variable and may play a role in evading the immune system. To study the immunogenicity of this antigen in the absence of the immunodominant repeats, the entire nonrepetitive region of the antigen was expressed in Escherichia coli as two fusion proteins with glutathione-S-transferase (GST) representing the amino terminal (GST-CSN) and the carboxy terminal domains (GST-CSC) of the CS antigen. The immunogenicity of these fusion proteins was studied in rabbits and different strains of mice. Antibody raised against both the CSN and CSC domains in both rabbits and every strain of mice recognized the native protein, as detected by immunofluorescence assay (IFA) using P. knowlesi sporozoites. A positive IFA reaction was also obtained with P. vivax sporozoites using antisera raised against the CSC domain. High titer antisera were raised in rabbits against both the domains, whereas mice showed comparatively low titers. On Western blots, mice showed specific response against the CSC domain. In both rabbits and mice, significant titers of antibodies were raised against region II, which has been shown to be the putative sporozoite binding site for hepatocytes in the case of P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9025690     DOI: 10.4269/ajtmh.1996.55.635

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  Molecular cloning and characterization of an antigenic protein with a repeating region from Clonorchis sinensis.

Authors:  T Y Kim; S Y Kang; I Y Ahn; S Y Cho; S J Hong
Journal:  Korean J Parasitol       Date:  2001-03       Impact factor: 1.341

2.  Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis.

Authors:  Dipankar Seth; Samrat Roy Choudhury; Saheli Pradhan; Siddhartha Gupta; Debjani Palit; Sumistha Das; Nitai Debnath; Arunava Goswami
Journal:  Curr Microbiol       Date:  2010-10-10       Impact factor: 2.188

Review 3.  Nanosilica-from medicine to pest control.

Authors:  T K Barik; B Sahu; V Swain
Journal:  Parasitol Res       Date:  2008-04-29       Impact factor: 2.289

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.